SCHEMBL29648201

SCHEMBL29648201

O=C1Cc2ccccc2N1F

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.55
NOTUM Q6P988 1/20 0.52
DDB1 Q16531 1/20 0.42
CRBN Q96SW2 1/20 0.42
KMT2A Q03164 2/20 0.42
CASP3 P42574 1/20 0.42
CASP6 P55212 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
HTR7 P34969 3/20 0.41
OPRM1 P35372 3/20 0.41
OPRK1 P41145 3/20 0.41
OPRL1 P41146 3/20 0.41
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
RNASEH1 O60930 1/20 0.41
CYP1A2 P05177 1/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1044845 1.00 HPGD (0.55) HPGDNOTUMDDB1CRBNKMT2A
SCHEMBL28735599 0.98 HPGD (0.53) HPGDNOTUMDDB1CRBNKMT2A
SCHEMBL29765632 0.82 HPGD (0.59) HPGDNOTUMDDB1CRBNKMT2A
SCHEMBL432918 0.79 MEN1 (0.54) NOTUMKMT2ACYP1A2MEN1CYP2A6
SCHEMBL30722457 0.76 HPGD (0.49) HPGDNOTUMDDB1CRBNKMT2A
SCHEMBL30642159 0.76 HPGD (0.57) HPGDNOTUMDDB1CRBNKMT2A
SCHEMBL3641405 0.76 HPGD (0.57) HPGDNOTUMDDB1CRBNKMT2A
SCHEMBL1464486 0.76 HPGD (0.57) HPGDNOTUMDDB1CRBNKMT2A
SCHEMBL3195836 0.74 RNASEH1 (0.60) HPGDNOTUMDDB1CRBNKMT2A
SCHEMBL1462133 0.74 HPGD (0.55) HPGDNOTUMDDB1CRBNKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12053465-B2 KCC2 expression enhancing compounds and uses thereof WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2024-08-06 US disclosed
US-20220378782-A1 KCC2 EXPRESSION ENHANCING COMPOUNDS AND USES THEREOF WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2022-12-01 US disclosed
US-11331313-B2 KCC2 expression enhancing compounds and uses thereof WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2022-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11331313-B2 KCC2 expression enhancing compounds and uses thereof MECP2, SLC1A2, GRIN2C HPGD 4849/4885NOTUM 4846/4885DDB1 758/4885
US-20220378782-A1 KCC2 EXPRESSION ENHANCING COMPOUNDS AND USES THEREOF MECP2, SLC1A2, GRIN2C HPGD 4849/4885NOTUM 4846/4885DDB1 758/4885
US-12053465-B2 KCC2 expression enhancing compounds and uses thereof MECP2, SLC1A2, GRIN2C HPGD 4849/4885NOTUM 4846/4885DDB1 758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.